How Single-Cancer Testing Could Revolutionize Diagnostics
Veracyte CEO Marc Stapley outlines how single-cancer testing is giving pathologists, clinicians, and patients an edge.
Read MorePosted by Chris Wolski | Mar 2, 2023 | Prostate, Unknown Origin & Other Cancer Types |
Veracyte CEO Marc Stapley outlines how single-cancer testing is giving pathologists, clinicians, and patients an edge.
Read MorePosted by Andy Lundin | Feb 15, 2023 | Cancer, Diagnostic Technologies |
CancerCare released an employer toolkit on biomarker testing to help employers involved in benefit design to make optimal decisions.
Read MorePosted by Andy Lundin | Jan 25, 2023 | Company News, Leukemia |
Alercell has launched a new website—Lena Diagnostics—dedicated to proprietary tests focused on early detection of cancer and leukemia.
Read MorePosted by Andy Lundin | Jan 10, 2023 | Lung Cancer |
Micronoma announced its OncobiotaLUNG assay received the Breakthrough Device Designation from the U.S. FDA for lung carcinoma detection.
Read MorePosted by Andy Lundin | Jan 9, 2023 | Lung Cancer |
PrognomiQ unveiled results from multi-omics study demonstrating the power of diverse molecular biomarkers in the early cancer detection.
Read More